Position in LLY
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$11,729,226
+$5,947,553 QoQ
Shares Held
9,779
+55.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.88%
of 13F equity value
Holder Rank
#1,167
of 4,605 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Stokes Capital Advisors, LLC holds $39,481,428 across 8 Drug Manufacturers - General names. LLY ranks #1 (29.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
9,779 | $11,729,226 | |
| 2 | JNJ |
Johnson & Johnson
|
43,686 | $11,094,933 | |
| 3 | ABBV |
AbbVie Inc.
|
37,456 | $9,425,427 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
35,370 | $4,468,645 | |
| 5 | AMGN |
Amgen Inc
|
3,061 | $1,108,449 | |
| 6 | MRK |
Merck & Co., Inc.
|
5,373 | $690,430 | |
| 7 | PFE |
Pfizer Inc
|
22,925 | $552,034 | |
| 8 | NVO |
Novo Nordisk A S
|
8,600 | $412,284 |
All Filings in LLY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,729,226 | 9,779 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $5,781,673 | 6,286 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $857,594 | 798 | Shares | Sole | 2026-01-12 | |
| No filing history on record for this holder in this stock. | ||||||